Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-24-000021
Filing Date
2024-11-12
Accepted
2024-11-12 09:20:35
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20240930.htm   iXBRL 10-Q 1088467
2 EX-31.1 exhibit311q32024.htm EX-31.1 10849
3 EX-31.2 exhibit312q32024.htm EX-31.2 10653
4 EX-32.1 exhibit321q32024.htm EX-32.1 5731
5 EX-32.2 exhibit322q32024.htm EX-32.2 5562
  Complete submission text file 0001012477-24-000021.txt   5103489

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20240930.xsd EX-101.SCH 29924
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20240930_cal.xml EX-101.CAL 63431
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20240930_def.xml EX-101.DEF 118539
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20240930_lab.xml EX-101.LAB 428553
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20240930_pre.xml EX-101.PRE 288655
69 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20240930_htm.xml XML 654928
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 241444099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)